Low-dose carvedilol reduces transmural heterogeneity of ventricular repolarization in congestive heart failure

Acta Pharmacologica Sinica

Volumn 28, Issue 8, 2007, Pages 1161-1165

  Zhong, Jiang Hua ^a,b   Chen, Xiao Pan ^a   Yun, Mei Ling ^a   Li, Wei Jing ^a   Chen, Yan Fang ^b   Yao, Zhen ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Carvedilol; Congestive heart failure; Midmyo cardium; Monophasic action potential duration; Repolarization

Indexed keywords

CARVEDILOL; DOXORUBICIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROL GROUP; CONTROLLED STUDY; DISPERSION; DRUG EFFECT; ENDOCARDIUM; EPICARDIUM; FEMALE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART OUTPUT; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RABBIT; STATISTICAL SIGNIFICANCE; VASCULAR RESISTANCE;

ACTION POTENTIALS; ANIMALS; BLOOD PRESSURE; CARBAZOLES; FEMALE; HEART FAILURE; MALE; PROPANOLAMINES; RABBITS; VENTRICULAR FUNCTION;

EID: 34547579580     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00613.x     Document Type: Article

References (27)

1. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990 65 : 421 81.
2. Bigger JT Jr. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 1987 75 : IV28 35.
3. Antzelevitch C, Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 2001 96 : 517 27.
4. Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 1995 26 : 185 92.
5. Okazaki O, Wei D, Harumi K. A simulation study of Torsade de Pointes with M cells. J Electrocardiol 1998 31 (Suppl 145 51.
6. Li Y, Xue Q, Ma J, Zhang CT, Qiu P, Wang L, et al. Effects of imidapril on heterogeneity of action potential and calcium current of ventricular myocytes in infarcted rabbits. Acta Pharmacol Sin 2004 25 : 1458 63.
7. Huang C, Bao M, Jiang H, Liu J, Yang B, Wang T. Differences in the changing trends of monophasic action potential duration and effective refractory period of the ventricular myocardium after myocardial infarction in vivo. Circ J 2004 68 : 1205 9.
8. Fowler MB. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure. Am J Cardiol 2004 93 : 35B 9B.
9. Kowey PR. A review of carvedilol arrhythmia data in clinical trials. J Cardiovasc Pharmacol Ther 2005 10 (Suppl 1 S59 68.
10. Bras-Silva C, Fontes-Sousa AP, Moura C, Areias JC, Leite-Moreira AF. Impaired response to ET (B) receptor stimulation in heart failure: functional evidence of endocardial endothelial dysfunction? Exp Biol Med (Maywood) 2006 231 : 893 8.
11. Kawai K, Qin F, Shite J, Mao W, Fukuoka S, Liang CS. Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol 2004 287 : H1003 12.
12. Korner PI, Oliver JR, Casley DJ. Effect of dietary salt on haemodynamics of established renal hypertension in the rabbit: Implications for the autoregulatory theory of hypertension. Hypertension 1980 2 : 794 801.
13. Ruan YF, Liu N, Zhou Q, Li Y, Wang L. Experimental study on the mechanism of sex difference in the risk of torsade de pointes. Chin Med J (Engl) 2004 117 : 538 41.
14. Zhang C, Li Y, Lu Z, Wu J, Wang C. Relationship between the U wave on electrocardiogram and the midmyocardium of the left ventricular wall. Chin Med J (Engl) 2002 115 : 509 12.
15. Wan YK, Holley L, Einstein R. Ventricular fibrillation and defibril-lation thresholds in sheep and dogs. Comp Biochem Physiol A Mol Integr Physiol 1998 121 : 77 82.
16. Qu L, Li F, Huang D. Effects of chronic heart failure on electrical remodeling of failing ventricles in rabbits. Chin J Card Pacing Electrophysiol 2000 14 : 75 8.
17. Yang Y, Tang Y, Ruan Y, Wang Y, Gao R, Chen J, et al. Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats. Jpn Heart J 2003 44 : 979 88.
18. Albert NM. Ventricular dysrhythmias in heart failure. J Cardiovasc Nurs 2004 19 (Suppl 6 S11 26.
19. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006 48 : 1977 85.
20. Anyukhovsky EP, Sosunov EA, Rosen MR. Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. In vitro and in vivo correlations. Circulation 1996 94 : 1981 8.
21. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res 1991 68 : 1729 41.
22. Akar FG, Spragg DD, Tunin RS, Kass DA, Tomaselli GF. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 2004 95 : 717 25.
23. Sosunov EA, Anyukhovsky EP, Rosen MR. Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: I. In vitro study. Circulation 1997 96 : 4011 8.
24. Sicouri S, Moro S, Elizari MV. D-sotalol induces marked action potential prolongation and early afterdepolarizations in M but not empirical or endocardial cells of the canine ventricle. J Cardiovasc Pharmacol Ther 1997 2 : 27 38.
25. Xie J, Dunn A, Tsikouris JP, Sun Y, Fan C, Kluger J, et al. A placebo controlled evaluation of the antifibrillatory effects of carvedilol. J Electrocardiol 2001 34 : 25 30.
26. Takusagawa M, Komori S, Matsumura K, Osada M, Kohno I, Umetani K, et al. The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats. J Cardiovasc Pharmacol Ther 2000 5 : 105 12.
27. Keating GM, Jarvis B. Carvedilol: a review of its use in chronic heart failure. Drugs 2003 63 : 1697 741.